Literature DB >> 14973385

Rat models of premalignant breast disease.

H J Thompson1, M Singh.   

Abstract

While a number of agents have been shown to induce mammary carcinogenesis in the rat, premalignant stages of the disease have been best characterized in chemically-induced models, specifically those initiated by either 7,12 dimethylbenz[alpha]anthracene (DMBA) or 1-methyl-1-nitrosourea (MNU). In general, it appears that epithelial cells in mammary terminal end buds or terminal ductules are the targets of carcinogenic initiation, and that a series of morphologically identifiable steps are involved in the development of mammary carcinoma. The premalignant steps include ductal hyperplasia of the usual type and carcinoma in situ of the cribriform or comedo type; atypical ductal hyperplasia has not been reported. Thus the histogenesis of lesions occurring in chemically induced mammary carcinogenesis in the rat is similar to that observed in the human; although, the spectrum of lesions observed in the rat is limited. Opportunities to investigate the biological and molecular characteristics of premalignant breast disease in the rat are presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 14973385     DOI: 10.1023/a:1009582012493

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  46 in total

Review 1.  Comparative study of human and rat mammary tumorigenesis.

Authors:  J Russo; B A Gusterson; A E Rogers; I H Russo; S R Wellings; M J van Zwieten
Journal:  Lab Invest       Date:  1990-03       Impact factor: 5.662

2.  Biochemical characterization of carcinogen-induced mammary hyperplastic aveolar nodule and tumor in the rat.

Authors:  T L Dao; S S Chistakos; R Varela
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

3.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.

Authors:  S Sukumar; V Notario; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

Review 4.  Development of human breast cancer.

Authors:  S R Wellings
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

5.  Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.

Authors:  I H Russo; J Russo
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

6.  Incidence of female breast cancer among atomic bomb survivors, 1950-1985.

Authors:  M Tokunaga; C E Land; S Tokuoka; I Nishimori; M Soda; S Akiba
Journal:  Radiat Res       Date:  1994-05       Impact factor: 2.841

7.  Site of origin of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in the rat.

Authors:  D Sinha; T L Dao
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

8.  Effect of high-dose, fractionated local irradiation on MNU-induced carcinogenesis in the rat mammary gland.

Authors:  D A Kantorowitz; H J Thompson; P Furmanski
Journal:  Carcinogenesis       Date:  1995-03       Impact factor: 4.944

9.  Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea.

Authors:  H J Thompson; J N McGinley; K Rothhammer; M Singh
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

10.  Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.

Authors:  D L McCormick; C B Adamowski; A Fiks; R C Moon
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  34 in total

1.  Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure.

Authors:  Tessa J Murray; Maricel V Maffini; Angelo A Ucci; Carlos Sonnenschein; Ana M Soto
Journal:  Reprod Toxicol       Date:  2006-10-24       Impact factor: 3.143

2.  Molecular histopathology by spectrally reconstructed nonlinear interferometric vibrational imaging.

Authors:  Praveen D Chowdary; Zhi Jiang; Eric J Chaney; Wladimir A Benalcazar; Daniel L Marks; Martin Gruebele; Stephen A Boppart
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

3.  4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats.

Authors:  Laura E Wright; Jennifer B Frye; Ashley L Lukefahr; Samuel L Marion; Patricia B Hoyer; David G Besselsen; Janet L Funk
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

4.  Dampness-Heat Accelerates DMBA-Induced Mammary Tumors in Rats.

Authors:  Wei Dong; Xi-Lan Tang; Guang-Bin Shang; Guo-Liang Xu; Wei-Feng Zhu; Hong-Ning Liu
Journal:  Chin J Integr Med       Date:  2017-09-15       Impact factor: 1.978

5.  Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.

Authors:  Anthony C Brandt; Lisa McNally; Ellen L Lorimer; Bethany Unger; Olivia J Koehn; Kiall F Suazo; Lisa Rein; Aniko Szabo; Shirng-Wern Tsaih; Mark D Distefano; Michael J Flister; Frank Rigo; Mark T McNally; Carol L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

Review 6.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

Review 7.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 8.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

9.  Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis.

Authors:  Benny Abraham Kaipparettu; Klaudia M Dobrzycka; Ora Britton; Adrian V Lee; Alan J Herron; Yi Li; Michael T Lewis; Daniel Medina; Steffi Oesterreich
Journal:  Mol Cancer       Date:  2009-03-06       Impact factor: 27.401

10.  Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.

Authors:  Hilal Kocdor; Mehmet Ali Kocdor; Tulay Canda; Duygu Gurel; Ruksan Cehreli; Osman Yilmaz; Mehmet Alakavuklar; Gul Guner
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.